Vaso Gains More Than 65% in Three Months: What's Driving the Stock?
Vaso Corporation (VASO) has gained 65.1% over the past three months, significantly outperforming its industry peers and the broader market. The company's strong performance is driven by improved Q2 2026 results, higher revenues from professional sales services and medical equipment, and the completion of its exit from IT services through the sale of NetWolves. Following strategic divestitures, VASO is now focused on healthcare operations including GE HealthCare equipment representation and proprietary medical devices. While the company maintains financial flexibility and a clearer business focus, risks remain from its dependence on GE HealthCare and competitive pressures in regulated medical device markets.